With fewer human research protection program staff in research institutions, mistakes will be made, and no one might be there ...

A well-placed biotech investor says U.S. policies are straining life sciences startups — and more disruption is coming.

Traditional animal models often fall short of predicting human outcomes. High costs and supply chain limitations (such as ...

Numerous service and staffing cuts at IHS facilities nationally have been caused by a new HHS contract review process, ...